MarketInOut Stock Screener Log In | Sign Up

Alpha Tau Medical Ltd Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Alpha Tau Medical Ltd Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,406.61 mln
Float64.10 mln
Earnings Date11/20/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

92 / 100
Top performer

Debt / Equity

0.34
Low leverage

ROE

-130
Deeply negative

ROA

-81.89
Deeply negative

Business Description

Alpha Tau Medical is an Israeli company developing a new type of radiation therapy designed to treat solid tumors. Their core technology, called Alpha DaRT, uses alpha particle emissions to target cancer cells and is currently being tested in clinical trials across a range of cancer types, including skin, prostate, pancreatic, lung, liver, and breast cancers. The company is based in Jerusalem and remains in the clinical stage as it works toward bringing this treatment to market.

Key Fundamentals

EPS-1.04
ROE-130
ROIC-176
ROA-81.89
Interest Cover-1.22
EBITDA, mln-48.76
EV / EBITDA-25.00

Quote Details

Last 2.96
Change -0.29 (-8.92%)
Open 3.25
Volume 2,086
Turnover 6,174.56
Average Volume 20,967

Financial Ratios

Leverage Ratio3.05
Current Ratio11.09
Price / Book7.25
Debt / Equity0.34

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.64% 11 / 100   
1 Month -26.37% 14 / 100   
2 Months -0.34% 57 / 100   
6 Months 123% 99 / 100   
1 Year 711% 100 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog